TUESDAY, Oct. 13, 2020 (HealthDay News) — Current angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use is associated with a slightly lower mortality risk in patients hospitalized with influenza or pneumonia, according to a study published online Oct. 1 in the Journal of the American Heart Association. Christian Fynbo Christiansen, M.D., Ph.D., from...